Authors
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
Getting Medications Right: Five Questions Pharmacists, Physicians Should Ask PatientsWith a coordinated, interprofessional team supporting them, patients are empowered with information at the point-of-care to help manage medication therapy problems as they arise.
Latest:
Patient and Provider Safety is at the Core of Mass COVID-19 Immunization EffortAs new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
ELCC 2025: Amivantamab Plus Lazertinib Effective in EGFR-Mutated NSCLC Versus Standard of CareNicolas Girard, MD, explains the benefits observed in the MARIPOSA clinical trial among patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated with amivantamab plus lazertinib.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Board Certification for Medical Science Liaisons: Implications for the Pharmaceutical IndustryMore than ever, confidence in objective, science-based data about therapeutics, such as the COVID-19 vaccine and other health care services, is a shared imperative across the pharmaceutical industry, health care communities, and the American public.
Latest:
Current Standards of Care in Platinum-Resistant Ovarian CancerFolate receptor α may be an important treatment target for ovarian tumors.
Latest:
Drug Shortages in Community Oncology: Ensuring Access to ChemotherapyPersistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
The Pharmacy Model Is ChangingEmbracing artificial intelligence and other tools will be necessary to push the field forward.
Latest:
The Landscape of Drug Development and the Pharmaceutical Industry in Italy: Challenges, Trends, and the Role of GenericsGenerics play a crucial role in mitigating drug shortages by offering a real alternative for 80% of drugs that are becoming increasingly unavailable in Italy.
Latest:
More Scrutiny Means Strict Regulation and OpportunityPharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Latest:
Assessing Quadruplet vs Triplet Regimens in Up-front Multiple Myeloma TreatmentResearch indicates quadruplet regimens may be a viable option for this disease.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
An Overview of Vitamins and Supplements in Multiple SclerosisBy examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Latest:
Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile InfectionPharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.
Latest:
Sex and Gender Inequalities in Oncology Care and Research PersistStrategies to advance sex and gender equality nationally and globally in oncology have been initiated in recent years.
Latest:
All it Takes is a Conversation: Deprescribing Benzodiazepines in Older AdultsBenzodiazepines have proven effective in managing anxiety and insomnia, but they heighten risk of falls, cognitive impairment, functional decline, and mortality among older adults.
Latest:
Pharmacists Can Leverage Future Roles in Outcomes-Based Payment ModelsThe pharmacist integration model filled in gaps in care that appeared to positively affect MIPS and PCMH quality measures.
Latest:
Pharmacy Technicians Can Master Professional IntegrityAs technicians are increasingly involved in decision-making, they must exude confidence and advocate for themselves
Latest:
Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia TreatmentBRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Latest:
During Summer Months, Counsel Patients on Preventing Lyme DiseaseEducation about prevention measures and early signs and symptoms of the condition are crucial
Latest:
Shaping the Future of Pharmacy: Trends to Watch at ASHP Midyear 2024Key trends shaping the future of health-system pharmacy include advanced medication management to address supply chain challenges, digital transformation to enhance pharmacy operations, and strategies for compliance with evolving regulations, all of which will be central topics at the ASHP Midyear 2024 meeting.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile InfectionPharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.
Latest:
Help Ensure Proper Medication Storage and DisposalEducation is key to providing information about proper techniques and bolstering patient safety.
Latest:
We Must Use the Vaccination Infrastructure We Already HavePharmacy and primary care are dramatically underallocated with COVID-19 doses compared with influenza efforts.
